Clinical Trials Logo

Congenital Hyperinsulinism clinical trials

View clinical trials related to Congenital Hyperinsulinism.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02835131 No longer available - Clinical trials for Congenital Hyperinsulinism

Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia

Start date: n/a
Phase:
Study type: Expanded Access

Congenital hyperinsulinism is a rare condition that can cause life-threatening hypoglycemia. Current treatment for congenital hyperinsulinism is often suboptimal, and such individuals may respond to a new somatostatin analog, pasireotide. This is a compassionate use study of the effects of pasireotide on individuals with suboptimally treated congenital hyperinsulinism.

NCT ID: NCT02533219 No longer available - Clinical trials for Congenital Hyperinsulinism

Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

[18F]-DOPA
Start date: n/a
Phase:
Study type: Expanded Access

The primary objective of this study is to evaluate the utility of [18F]-DOPA PET to provide improved presurgical planning and distinguish between focal and diffuse forms of HI. The investigators will perform descriptive analysis, relying on visual analysis to diagnose and localize a focal lesion. Our findings will be compared to surgical histopathology to determine sensitivity and specificity or this technique. The investigators will also track patient surgical outcomes, specifically whether the patient is surgically "cured" or still requires medical management to control residual hypoglycemia.